Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survival without concurrent chemotherapy for locoregionally advanced nasopharyngeal carcinoma treated with induction chemotherapy plus intensity-modulated radiotherapy: Single-center experience from an endemic area.
Fangzheng W, Chuner J, Haiyan Q, Quanquan S, Zhimin Y, Tongxin L, Jiping L, Peng W, Kaiyuan S, Zhenfu F, Yangming J. Fangzheng W, et al. Among authors: yangming j. Medicine (Baltimore). 2019 Dec;98(51):e18484. doi: 10.1097/MD.0000000000018484. Medicine (Baltimore). 2019. PMID: 31861031 Free PMC article.
Optimal induction chemotherapeutic regimen followed by concurrent chemotherapy plus intensity-modulated radiotherapy as first-line therapy for locoregionally advanced nasopharyngeal carcinoma.
Wang F, Chuner J, Lei W, Fengqin Y, Zhimin Y, Quanquan S, Tongxin L, Zhenfu F, Yangming J. Wang F, et al. Among authors: yangming j. Medicine (Baltimore). 2020 Sep 25;99(39):e22283. doi: 10.1097/MD.0000000000022283. Medicine (Baltimore). 2020. PMID: 32991429 Free PMC article. Clinical Trial.
Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis.
Fangzheng W, Chuner J, Zhimin Y, Quanquan S, Tongxin L, Min X, Peng W, Bin L, Sakamoto M, Yuezhen W, Fengqin Y, Zhenfu F, Yangming J. Fangzheng W, et al. Among authors: yangming j. Oncotarget. 2017 Oct 6;8(55):94117-94128. doi: 10.18632/oncotarget.21587. eCollection 2017 Nov 7. Oncotarget. 2017. PMID: 29212214 Free PMC article.
Optimization of the margin expanded from the clinical to the planned target volume during intensity-modulated radiotherapy for nasopharyngeal carcinoma.
Fangzheng W, Quanquan S, Chuner J, Zhimin Y, Shuangyan Y, Huanhuan Y, Jianfang S, Sakamoto M, Weifeng Q, Zhenfu F, Yangming J, Yuezhen W. Fangzheng W, et al. Among authors: yangming j. Oncotarget. 2017 Nov 20;8(66):110201-110208. doi: 10.18632/oncotarget.22518. eCollection 2017 Dec 15. Oncotarget. 2017. PMID: 29299141 Free PMC article.
Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma.
Fangzheng W, Chuner J, Quanquan S, Zhimin Y, Tongxin L, Jiping L, Sakamoto M, Peng W, Kaiyuan S, Weifeng Q, Zhenfu F, Yangming J. Fangzheng W, et al. Among authors: yangming j. Oncotarget. 2017 Dec 14;8(70):115469-115479. doi: 10.18632/oncotarget.23300. eCollection 2017 Dec 29. Oncotarget. 2017. PMID: 29383174 Free PMC article.